In the last week, the trend observed in the previous one is confirmed
"with 26% of the total cases diagnosed in the school age population (under 20 years).
48% of school age cases were diagnosed in the age group 6-11 years, 36% in the 12-19 age group and only 11% and 5% were diagnosed, respectively between 3 and 5 years and under 3 years ".
These are the data contained in the
extended report of the Higher Institute of Health (Iss)
which integrates the weekly monitoring on Covid, published today, in particular on the distribution of cases in the population 0-19 years.
After 150 days from the completion of the vaccination cycle, "the effectiveness of the vaccine in preventing the disease, both in the symptomatic and asymptomatic form, drops from 71.5% to 30.1%".
Vaccination efficacy in preventing cases of severe disease remains high: in vaccinated with a complete cycle for less than 5 months it is 92.7%, while it falls to 82.2% in vaccinated persons who have completed the vaccination cycle for more than 150 days .
The efficacy in preventing diagnosis and cases of severe disease rises to 71.0% and 94.0% respectively in subjects vaccinated with an additional / booster dose.
Furthermore, the risk of intensive care for the unvaccinated compared to those with the third dose "is 85 times greater for those over 80;
12.8 times greater for the 60-79 age group; 6.1 times greater for the 40- 59 years old.
